Healthcare -
Biotechnology - NASDAQ - US
$ 39.24
4.39 %
$ 2.41 B
Market Cap
9.28
P/E
PTGX - CHANGE IN WORKING CAPITAL
Change in Working Capital PTGX - Protagonist Therapeutics, Inc.
-19.5 M
LAST VALUE
-142.64%
2 YEAR CAGR
-1.61%
5 YEAR CAGR
0.00%
10 YEAR CAGR